Septerna To Participate In Upcoming Investor Conferences
Guggenheim 3rd Annual Healthcare Innovation Conference – Boston
Fireside chat on Tuesday, November 10, 2026, at 10:00 a.m. ET
Stifel 2026 Healthcare Conference – New York
Fireside chat on Wednesday, November 11, 2026, at 1:20 p.m. ET
UBS Global Biopharma Conference – London
Fireside chat on Monday, November 16, 2026, at 2:00 p.m. GMT
9th Annual Evercore Healthcare Conference – Miami
Fireside chat on Tuesday, December 1, 2026, at 7:55 a.m. ET
A live webcast of each presentation will be available in the investors section of the company's website at . The webcasts will be archived for at least 30 days following the presentation.
About Septerna
Septerna, Inc. is a clinical-stage biotechnology company with a world-class team of GPCR experts and drug developers advancing cutting-edge science to unlock the full potential of GPCR therapies for patients with significant unmet needs. The company's proprietary Native Complex Platform® is designed to enable new approaches to GPCR drug discovery and has led to the development of a diverse pipeline of novel oral small molecule drug candidates. Septerna is advancing programs in endocrinology, immunology and inflammation, metabolic diseases and additional therapeutic areas, both independently and with partners. For more information, please visit .
Investor Contact:
Renee Leck, THRUST
...
Media Contact:
Carly Scaduto, THRUST
...
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Comments
No comment